Page last updated: 2024-10-16

gamma-aminobutyric acid and Angiomatosis Oculoorbital-Thalamic Syndrome

gamma-aminobutyric acid has been researched along with Angiomatosis Oculoorbital-Thalamic Syndrome in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tyzio, R1
Khalilov, I1
Represa, A1
Crepel, V1
Zilberter, Y1
Rheims, S1
Aniksztejn, L1
Cossart, R1
Nardou, R1
Mukhtarov, M1
Minlebaev, M1
Epsztein, J1
Milh, M1
Becq, H1
Jorquera, I1
Bulteau, C1
Fohlen, M1
Oliver, V1
Dulac, O1
Dorfmüller, G1
Delalande, O1
Ben-Ari, Y1
Khazipov, R1

Other Studies

1 other study available for gamma-aminobutyric acid and Angiomatosis Oculoorbital-Thalamic Syndrome

ArticleYear
Inhibitory actions of the gamma-aminobutyric acid in pediatric Sturge-Weber syndrome.
    Annals of neurology, 2009, Volume: 66, Issue:2

    Topics: Action Potentials; Bumetanide; Cerebral Cortex; Diazepam; Epilepsy; Excitatory Amino Acid Antagonist

2009